These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 36003063

  • 41. Overexpression of miR-623 suppresses progression of hepatocellular carcinoma via regulating the PI3K/Akt signaling pathway by targeting XRCC5.
    Ren F, Su H, Jiang H, Chen Y.
    J Cell Biochem; 2020 Jan; 121(1):213-223. PubMed ID: 31190447
    [Abstract] [Full Text] [Related]

  • 42. MiR-27a-3p enhances the cisplatin sensitivity in hepatocellular carcinoma cells through inhibiting PI3K/Akt pathway.
    Yang Y, Yang Z, Zhang R, Jia C, Mao R, Mahati S, Zhang Y, Wu G, Sun YN, Jia XY, Aimudula A, Zhang H, Bao Y.
    Biosci Rep; 2021 Dec 22; 41(12):. PubMed ID: 34096570
    [Abstract] [Full Text] [Related]

  • 43. MicroRNA-3127 promotes cell proliferation and tumorigenicity in hepatocellular carcinoma by disrupting of PI3K/AKT negative regulation.
    Jiang J, Zhang Y, Guo Y, Yu C, Chen M, Li Z, Tian S, Sun C.
    Oncotarget; 2015 Mar 20; 6(8):6359-72. PubMed ID: 25849943
    [Abstract] [Full Text] [Related]

  • 44. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C, Shan Z, Hong J, Yang L.
    Int J Oncol; 2017 Jul 20; 51(1):235-244. PubMed ID: 28534966
    [Abstract] [Full Text] [Related]

  • 45. MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1.
    Huang XP, Hou J, Shen XY, Huang CY, Zhang XH, Xie YA, Luo XL.
    FEBS J; 2015 Feb 20; 282(3):579-94. PubMed ID: 25475121
    [Abstract] [Full Text] [Related]

  • 46. MicroRNA-134 inhibits tumor stem cell migration and invasion in oral squamous cell carcinomas via downregulation of PI3K-Akt signaling pathway by inhibiting LAMC2 expression.
    Zhou YM, Yao YL, Liu W, Shen XM, Shi LJ, Wu L.
    Cancer Biomark; 2020 Feb 20; 29(1):51-67. PubMed ID: 32568182
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma.
    Li D, Zhang Y, Zhang H, Zhan C, Li X, Ba T, Qiu Z, E F, Lv G, Zou C, Wang C, Si L, Zou C, Li Q, Gao X.
    J Exp Clin Cancer Res; 2018 Mar 05; 37(1):46. PubMed ID: 29506532
    [Abstract] [Full Text] [Related]

  • 50. MiR-92a-3p Promotes the Malignant Progression of Hepatocellular Carcinoma by Mediating the PI3K/AKT/mTOR Signaling Pathway.
    Wang L, Cui M, Qu F, Cheng D, Yu J, Tang Z, Cheng L, Wei Y, Wu X, Liu X.
    Curr Pharm Des; 2021 Mar 05; 27(29):3244-3250. PubMed ID: 34126886
    [Abstract] [Full Text] [Related]

  • 51. MicroRNA-93 activates c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by directly inhibiting PTEN and CDKN1A.
    Ohta K, Hoshino H, Wang J, Ono S, Iida Y, Hata K, Huang SK, Colquhoun S, Hoon DS.
    Oncotarget; 2015 Feb 20; 6(5):3211-24. PubMed ID: 25633810
    [Abstract] [Full Text] [Related]

  • 52. MiR-126-5p Promotes Tumor Cell Proliferation, Metastasis and Invasion by Targeting TDO2 in Hepatocellular Carcinoma.
    Ai Y, Luo S, Wang B, Xiao S, Wang Y.
    Molecules; 2022 Jan 10; 27(2):. PubMed ID: 35056756
    [Abstract] [Full Text] [Related]

  • 53. LncRNA TMPO-AS1 promotes hepatocellular carcinoma cell proliferation, migration and invasion through sponging miR-329-3p to stimulate FOXK1-mediated AKT/mTOR signaling pathway.
    Guo X, Wang Y.
    Cancer Med; 2020 Jul 10; 9(14):5235-5246. PubMed ID: 32462698
    [Abstract] [Full Text] [Related]

  • 54. HHLA2 promotes hepatoma cell proliferation, migration, and invasion via SPP1/PI3K/AKT signaling pathway.
    Wang J, Yang K, Yang X, Jin T, Tian Y, Dai C, Xu F.
    Mol Carcinog; 2024 Jul 10; 63(7):1275-1287. PubMed ID: 38578157
    [Abstract] [Full Text] [Related]

  • 55. miR-199a/b-3p inhibits HCC cell proliferation and invasion through a novel compensatory signaling pathway DJ-1\Ras\PI3K/AKT.
    Ma LN, Wu LN, Liu SW, Zhang X, Luo X, Nawaz S, Ma ZM, Ding XC.
    Sci Rep; 2024 Jan 02; 14(1):224. PubMed ID: 38168113
    [Abstract] [Full Text] [Related]

  • 56. SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway.
    Zhang M, Liu S, Chua MS, Li H, Luo D, Wang S, Zhang S, Han B, Sun C.
    Cell Death Dis; 2019 Aug 13; 10(8):612. PubMed ID: 31406106
    [Abstract] [Full Text] [Related]

  • 57. Upregulating microRNA-373-3p promotes apoptosis and inhibits metastasis of hepatocellular carcinoma cells.
    Li H, Wang N, Xu Y, Chang X, Ke J, Yin J.
    Bioengineered; 2022 Jan 13; 13(1):1304-1319. PubMed ID: 34983307
    [Abstract] [Full Text] [Related]

  • 58. MiR-126-3p suppresses tumor metastasis and angiogenesis of hepatocellular carcinoma by targeting LRP6 and PIK3R2.
    Du C, Lv Z, Cao L, Ding C, Gyabaah OA, Xie H, Zhou L, Wu J, Zheng S.
    J Transl Med; 2014 Sep 22; 12():259. PubMed ID: 25240815
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.